POST Online Media Lite Edition



 

CVS, Aetna have U.S. approval for $69 billion deal

Staff Writer |
CVS Health got U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna, the Justice Department said on Wednesday.

Article continues below




The companies have said they will save administrative and patient care costs when they combine, in part by steering Aetna customers to walk-in clinics in CVS stores for less expensive medical services.

CVS could offer more preventive care services and screenings in its clinics, such as enabling patients with diabetes to monitor blood sugar levels, avoiding higher cost visits to doctors or emergency rooms.

CVS aims to cut costs by $750 million annually by the end of the second year after the deal closes.

The Department of Justice announced that it is requiring CVS Health Corporation (CVS) and Aetna Inc. (Aetna) to divest Aetna’s Medicare Part D prescription drug plan business for individuals in order to proceed with their $69 billion merger.


What to read next

CVS Health to acquire Aetna in $69 billion deal
Aetna plans $3.3 billion accelerated share repurchase
Judge blocks Aetna-Humana deal, says it's anti-competitive